Myeloid derived suppressor cell expression in newborn infants: an observational cohort study

Myeloid derived suppressor cell expression in newborn infants: an observational cohort study
Enrolling By Invitation
1-1 years
All
Phase N/A
260 participants needed
1 Location

Brief description of study

This research study is being conducted to study a type of white blood cells called MDSC in newborn babies. These cells help regulate our body’s immune system. Learning more about these cells may help us to better understand immune function in newborn babies.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Newborn
  • Age: Between 1 Years - 1 Years
  • Gender: All

Male or Female Newborn infants

Updated on 01 Aug 2024. Study ID: 843977
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research